SEROPREVALENCE OF HIV, HBV, HCV AND SYPHILIS AMONG BLOOD DONORS IN KIMS BLOOD BANK HUBBALLI, KARNATAKA, A TERTIARY CARE HOSPITAL

S.S. GIRIYAN¹, N. SINDHUSHREE²*
¹Department of Pathology, Karnataka Institute of Medical Sciences, Rajiv Gandhi University of Health Sciences, Hubballi, 580021, India
²Department of Pathology, Karnataka Institute of Medical Sciences, Rajiv Gandhi University of Health Sciences, Hubballi, 580021, India
* Corresponding Author : dr.sindhu.kshitij@gmail.com

Received : 18-01-2018     Accepted : 07-02-2018     Published : 30-03-2018
Volume : 10     Issue : 3       Pages : 1020 - 1023
Int J Microbiol Res 10.3 (2018):1020-1023
DOI : http://dx.doi.org/10.9735/0975-5276.10.3.1020-1023

Keywords : HBV, HCV, HIV, Prevalence, TTI
Academic Editor : Dr Ranjana Hawaldar, Dr Priyadarshini D, Puttappa Shruthi Hosur, Dr Manoj P
Conflict of Interest : None declared
Acknowledgements/Funding : Author thankful to Karnataka Institute of Medical Sciences, Rajiv Gandhi University of Health Sciences, Hubballi, 580021
Author Contribution : All authors equally contributed

Introduction: With every unit of blood there is 1% chance of transfusion associated problems including transfusion transmitted infections (TTI). These TTIs include hepatitis B (HBV), hepatitis C (HCV), Human Immunodeficiency Virus (HIV), syphilis, and less commonly malaria, toxoplasmosis, brucellosis, other viral infections. The process of preventing the transmission of TTIs through blood transfusion presents one of the greatest challenges of transfusion medicine. Aim: The aim of our study was to find out the seroprevalence of infectious markers of TTIs among the blood donors. Materials and methods: A 9 year retrospective study was carried out in the blood bank of KIMS, Hubballi, Karnataka, from January 2007 to December 2015. From the donor’s blood units, 5 ml blood samples were obtained for serological testing. All the samples were screened for HIV, HCV, HBV by ELISA and RPR for syphilis. Results: A total of 80312 apparently healthy donors were analyzed for prevalence of TTIs of which 50735 (63.17%) were replacement donors and 29577 (36.83%) were voluntary donors. The overall prevalence of TTIs was 2047/80312 (2.5 %). The overall prevalence of HIV, HBV, HCV and syphilis among donors were 283(0.35%), 1556 (1.9%), 195 (0.2%) & 13(0.01%) respectively. Conclusion: The current infectious disease pattern and trends in donor population can help in planning of future blood transfusion related health challenges. Encouraging female population as well as voluntary blood donors for blood donation will increase the number of donors and safe donor pool.

1. Zafar N. (2000)J Coll Physicians Surg Pak,10, 90-92.
2. Mahmud Z.(2009)JAFMC Bangladesh, 5(1), 1-2.
3. WHO's certified [Internet] Media centre (IL): Blood Safety and Availability/Fact Sheet No 279; June 2017. Available from http://www.who.int/mediacentre/factsheets/fs279/en/. Accessed on October, 2017
4. Agravat AH, Gharia AA, Pujara K, Dhruva GA. (2014) Int J Biomed Adv Res., 4, 623-628.
5. WHO's certified. Menabde N(IL): World Blood Donor Day: Safe Blood for Saving Mothers ;June 2014:
a. http://www.searo.who.int/india/world_blood_donor_day_2014_message_wr.pdf. Accessed on October, 2014.
6. Widmann FK (1985) Aglington Ust., 325-44.
7. Mollison PL and Engelfriet CP (2005) Contreras M. Infectious agents transmitted by transfusion. In: Klein H, Anstee D, eds. Mollison's Blood Transfusion in Clinical Medicine. 11th ed. Massachusetts: Blackwell Publishing, 701-702
8. Srikrishna A, Sitalakshmi S and Damodar P.(1999) Indian J Pathol Microbiol., 42,411–416
9. Government of India. Drugs and Cosmetics rules. (1945) Available at: http://www.cdsco.nic.in/html/DrugscosmeticsAct.pdf.
10. National Blood Policy. National AIDS Control Organization, Ministry of Health and Family Welfare, Government of India, New Delhi. 2003 (reprint 2007
11. Manual on quality standards for HIV testing laboratories. National AIDS Control Organization, Ministry of Health and Family Welfare, Government of India, New Delhi. 2007.
12. Khan Z T, Asim S, Tariz Z, Ehsan I A, Malik R A, Ashfaq B et al. (2007) Int J Pathol., 5, 21–25.
13. Kuliya A Gwarzo.(2009)The Internet Journal of Infectious Diseases.,9,1.
14. Global Database on Blood Safety - World Health Organization (2011) Available at www.who.int › global_database › GDBS Accessed on April 2017.
15. WHO Guidelines of Blood Transfusion Safety Appia, CH-1211, Geneva27, Switzerland.
16. Voluntary Blood Donation Programme - an Operational Guideline, National AIDS Control Organization, Ministry of Health and Family Welfare Government of India, New Delhi, India. 2007. Available from URL: http://naco.gov.in/sites/default/files/Annual Report 2015-16_NACO.pdf. Accessed on April 2017.
17. NACO (2015) ‘Annual report 2015 -16’. Available from: http://naco.gov.in/sites/default/files/Annual Report 2015-16_NACO.pdf Accessed on April 2017
18. Koshy JM, Manoharan A, John M, Kaur R and Kaur P.(2014) Chrismed J Health Res.,1,91-94.
19. Gupta N, Kumar V, Kaur A. (2004) Indian J Med Sci.,58, 255-257.
20. Datta S. (2008) Virol J., 5,156.
21. Panda M and Kar K. (2008)Indian J Public Health.,52, 43-44.
22. WHO. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium.(1999) J Viral Hepat.,6,35-47.
23. Sood G, Chauhan A, Sehgal S, Agnihotri S, Dilawari JB. (1992) Indian J Gastroenterol., 11,44.
24. Garg S, Mathur DR and Garg DK. (2001) Indian J Pathol Microbiol., 44, 409-412.
25. Pahuja S, Sharma M, Baitha B and Jain M. (2007) Jpn J Infect Dis., 60, 389-391.
26. Bihl F, Castelli D, Marincola F, Dodd RY and Brander C.(2007) J Transl Med, 5, 25.
27. Chiavetta JA, Maki E, Gula CA, Newman A. (2000) Vox Sang 2000, 78 (Suppl 1), 360.
28. India HIV Estimations (2015) Naco Available from Url: www.naco.gov.in › sites › default › files › India HIV Estimations 2015 - Naco Accessed on April 2017.
29. Karnataka State Aids Prevention Society (2014-2015) Available from Url:http://www.ksaps.gov.in/blood_safty.html Accessed on April 2017.
30. Sarin S K, Saxena R and Sundaram K R. (1998) Sarin S K, Hess G eds;1st Edn. CBs publishers &distributors New Delhi 212-218.
31. Hans R and Marwaha N. (2014) Asian J Transfus Sci., 8 , 2-3.
32. Fernandes H, D’souza PF and D’souza PM. (2010) Indian J Hematol Blood Transfus, 26, 89-91.
33. Pallavi. P, Ganesh C.K, Jayashree. K, Manjunath G.V et al. (2011) Indian J Hematol Blood Transfus, 27, 1–6.
34. World health organization South-East Asia Regional Office. Prevention of hepatitis B in India-an overview. Available from: whqlibdoc.who.int/searo/2002/SEA_Hepat.-5.pdf, accessed on June 10, 2014.
35. Karmakar PR, Shrivastava P and Ray TG. (2014) Indian J Public Health, 58, 61-4.
36. Mandal R and Mondal K. (2015) Journal of Traditional and Complementary Medicine, 1-6.
37. Sushma K., Ritesh K. and Ramesh K. S. (2016) Open Science Journal,1(2).
38. Bodarya O, Shrivastav AV, Bhavsar U, Ramanuj A, Joshi JR and Agnihotri AS. (2015) Muller Journal of Medical Sciences and Research, 6(2),142.
39. Fulzele P P, Yasmeen K, Akanksha G, Richa P, Arsala M and Surekha K. (2017) International Journal of Contemporary Medical Research, 4(2).
40. Gopi H. Dobariya, Kruti A. Raja, Chirag A. Unagar, Amrish N. Pandya, Jitendra N. Patel, Mayur A. Jarag and Sangita J. Wadhwani. (2016) Int J Res Med Sci., 4(9), 4123-4127.
41. Kumar A, Sharma SM, Ingole NS and Gangane N. (2014) Muller J Med Sci Res, 5,113-6.
42. Agrawal P C,Naik R, Panda K M, Chawda H et al.(2016) Journal of Medical Science And clinical Research , 4(11).
43. Makroo RN, Hegde V, Chowdhry M, Bhatia A and Rosamma NL. (2015) The Indian journal of medical research, 142(3),317-322.
44. Arya DR, Mahawar NL, Pachaury R, Bharti A, Sharma L, Kumar H, et al. (2016) Indian j health sci, 9,77-81.
45. Sachdeva A, Gupta A, Sharma B, Sharma D and Sharma N. (2016) Int J Res Med Sci ,4, 5002.
46. Raman M H and Krishna MC. (2016) Scholars Journal of Applied Medical Sciences, 4(10B),3702-3706.
47. Vijaya K., R. Shyamala and Durga Prasad A. (2017) Int. J. Curr. Microbiol. App. Sci., 6(3), 1293-1295.
48. Khalid Ahmed, B.S. Akshantha, K.L. Shoba and B. Sumangala. (2016) Int. J. Curr. Microbiol.App.Sci., 5(9), 346-354.
49. Lathamani K, Bhaktha G, Nayak S and Kotigadde S. (2013) Int J Curr Microbiol App Sci., 2(10), 249-52.
50. A. Vinit, B. Geetha, and V. Sridevi (2015) International Journal of Pharmaceutical, Chemical and Biological Sciences, 5(1), 126–128.
51. Victor J. Drew, Lassina Barro, Jerard Seghatchian and Thierry Burnouf (2017) BloodTransfus, 15(6), 512–521